Acrónimos

C&G · Cockroft-Gault CAC · Cociente Albumina-Creatinina CaCo · Cancer de Colon CAD · Cetoacidosis diabética CAGRI · cagrilintida CALIBER · Cardiovascular disease research using Linked Bespoke studies and Electronic health Records CANTAYA-SU · Canagliflozin _treatment and Trial Analysis-Sulfonylurea CANVAS · Canagliflozin Cardiovascular Assessment Study CAPTURE · An International Survey of the Occurrence of Diseases That Affects the Heart and Blood Vessels Among People With Type 2 Diabetes CARDIA · Coronary Artery Risk Development in Young Adults CARDS · Collaborative Atorvastatin Diabetes Study CARE · Consultation And Relational Empathy CaReMe · CArdioRenal and Metabolic CARMELINA · Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus  CAROLINA · CARdiovascular Outcomestudy of LINAgliptin versus glimepiride in patientswithtype 2 diabetes CASCADE · CArdiovaSCulAr Diabetes & Ethanol CB · Cirugía Bariátrica CC · Circunferencia de Cintura CCAA · Comunidades Autonomas CCI · Indice de Contractilidad Cardiaca o cardiac contractility index CCI · Cardiac Contractility Index ( Índice de Contractilidad Cardíaca) CCK · ColeCistokinina CCL · Contaje Células Leucocitarias CCM · Chronic Care Model CCR · Cáncer ColoRrectal CCS · Canadian Cardiovascular Society CCS/CHFS · Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in Adults” CCTG · Canadian Cancer Trials Group CCW · Cloning Censorship Weighting (método de clonación-censura-ponderación) CCW · Cloning Censorship Weighting (método de clonación-censura-ponderación) CDA · Canadian Diabetes Association. CDARS · Clinical Data Analysis and Reporting System CDC · Centers for Disease Control and Prevention CDM · Core Diabetes Model CDM · Clinformatics Data Mart CF · Cuello Femoral CGM · Continuous Glucose Monitoring CHANCES · Consortium on Healthand Ageing Network of Cohorts in Europe and the United State  CHARM · Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity CHARM-ALTERNATIVE · Candesartan in Heart Failure. Assess of Reduction in Mortality & Morbidity.  CHARM-PRESERVED · Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity CHC · Carcinoma HepatoCelular CHEERS · Consolidated Health Economic Evaluation Reporting Standards CHESS · COVID-19 Hospitalisation in England Surveillance System CHIEF-HF · Canagliflozin on Health status qualIty of lifE and Functional status in Heart Failure CHS · Cardiovascular Health Study CI · Cardiopatia Isquémica CIE · Clasificación Internacional de Enfermedades CINAHL · Cumulative Index to Nursing and Allied Health Literature CK-MB · Creatinina Kinasa, isoenzima específica del miocardio. CKD-EPI · Chronic Kidney Disease Epidemiology  CKD-REIN · Chronic Kidney Disease Renal Epidemiology and Information Network CKD273 · Chronic kidney disease 273 CL · Columna Lumbar CLEAR OUTCOMES · Cholesterol Lowering via Bempedoic Acid, an ACL-Inhibiting Regimen CM · Cáncer de Máma CMD · CardioMiopatía Diabética CMDB · Conjunto Mínimo de Datos Básicos CMRF · CardioMetabolic Risk Factor (Factor de Riesgo Cardiometabólico) CMS · Centers for Medicare & Medicaid Services CMUH · China Medical University Hospital CNIC · Centro Nacional de Investigaciones Cardiovasculares CNS · Central Nervous System CNT · Coxib and traditional non-steroidal anti-inflammatory drugs (tNSAID) Trialists' CNT · Coxib and traditional non-steroidal anti-inflammatory drugs (tNSAID) Trialists' CoefV · Coeficiente de Variación CogniD · Cognición y Diabetes COM-B · Modelo de Capacidad, Oportunidad, Motivación y Comportamiento CONCORD · Cancer survival in five continents: a worldwide population-based study CONFIDENCE · COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint CONGA · Continuous Overlapping Net Glycemic Action CONQUER · Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults  CONSORT · Consolidated Standards of Reporting Trials Cor-SARS-2 · Coronavirus–Severe Acute Respiratory Syndrome Coronavirus 2 and Diabetes Outcomes CORDIOPREV · The CORonary Diet Intervention with Olive oil and cardiovascular PREVention CORDIOPREV · CORonary Diet Intervention With Olive Oil and Cardiovascular PREVention CORONADO · Coronavirus Disease and Diabetes Outcome CoV · Coronavirus COVID19 · Coronavirus Disease 2019 COX-2 · Inhibidores duales de la Ciclooxigenasa-2 CP · Cáncer de Pulmón CPAP · Continuous Positive Airway Pressure CPRD · Clinical Practice Research Datalink CR · Cardio-Renal CRA · Cociente de Riesgos Ajustado CRAVED · ICD-10 symptoms of food related substance use disorder CREDENCE · Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation CRESCENDO · Comprehensive Rimonabant Evaluation Study of Cardiovascular Endpoints and Outcomes CRIC · Chronic Renal Insufficiency Cohort CRO · Cáncer Relacionado con Obesidad CROSSRAODS · Calorie Reduction Or Surgery: Seeking Remission for Obesity And Diabetes CTGF · Connective Tissue Growth Factor (factor de crecimiento tisular conectivo) CTT · Cholesterol Treatment Trialists CUIMC/NYP · Columbia University Irving Medical Center/New York Presbyterian Hospital CV · CardioVascular CVD-REAL · Comparative  Effectiveness of Cardiovascular Outcomes in New Users of SGLT-2 Inhibitors CVOT · CardioVascular Outcome Trials (ensayos clínicos de seguridad cardiovascular) CVRD · CardioVascular and/or Renal Disease(enfermedad cardiovascular y/o renal)